Skip to main content

Table 3 The association between the molecular subtypes of the primary tumours and chemotherapy response rates

From: Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer

 

Response

Molecular subtype

Basal

Luminal A

Luminal B

HER2

N

%

N

%

N

%

N

%

A-CT

no

5

62,5%

12

48,0%

8

50,0%

2

28,6%

yes

3

37,5%

13

52,0%

8

50,0%

5

71,4%

NA/NT-CT

no

5

83,3%

12

75,0%

9

75,0%

2

66,7%

yes

1

16,7%

4

25,0%

3

25,0%

1

33,3%

   

0

 

0

 

0

 

T-CT

no

9

90,0%

4

36,4%

10

83,3%

2

66,7%

yes

1

10,0%

7

63,6%

2

16,7%

1

33,3%

  1. Abbreviations: A-CT anthracycline containing chemotherapy, NA/NT-CT non-anthracyline/non-taxane containing chemotherapy, T-CT taxane containing chemotherapy